Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 21, 2019
Fred Hutch–led team receives $6M to study deadly brain tumor
Researchers seek deeper understanding of ependymoma biology to aid treatment discovery
Bringing personalized oncology to cancer prediction — and prevention
Unique $2.4M NCI-NIEHS award teams Hutch cancer geneticists, epidemiologists and oncologists to use mutation rate to predict individual cancer risk
Brain cancer subtype caused by single gene fusion
Hutch researchers create genetically relevant model to examine the biology of supratentorial ependymomas
Nanoparticles take immunotherapy in new direction
Hutch scientist to use nanoparticles to reprogram macrophages to tackle brain tumors
Study sheds light on why brain cancers become aggressive and treatment-resistant
New computational method sheds light on how cancer-contributing genes make brain tumors more aggressive and radiation-resistant
Dr. Kevin Cheung receives prestigious ‘Era of Hope’ Scholar Award
$4.1 million, four-year award to advance understanding of breast cancer metastasis
Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech
Fred Hutch experts lend their predictions for the coming year’s advances
Osteopontin: can’t live with it, can’t live without it in glioblastoma
From the Holland Lab, Human Biology Division
6 things to know about glioblastoma
Following Sen. John McCain’s diagnosis, Fred Hutch experts offer ‘the long view’ on brain cancer research
IDH1 mutant (or methylation), stops monocyte migration
From the Holland Lab, Human Biology Division
Good News: Bezos family funding accelerates glioma immunotherapy research
Celebrating faculty and staff achievements
How mutations in a single gene alter the course of a deadly brain cancer
New laboratory study of glioma links more aggressive immune response to poorer prognosis
Single gene alters immune response to deadly brain cancer
A new study of glioma in humans and mice links more aggressive immune response to poorer prognosis
How Dr. Barry Stoddard's science fueled promising therapy for glioblastoma — the disease that killed his mom
How Dr. Barry Stoddard's lab work helped create an experimental drug for glioblastoma — the same disease that killed his mother
‘A crack in the door’: Glimpses of hope for the future of brain cancer care
Fred Hutch researchers discuss brain tumor treatments in the works — and what’s coming next
Reaching for answers
Researchers’ friends and family see scientists as conduits for hope
Welcome to the Academy!
The president and director becomes the ninth Fred Hutch faculty member inducted into the NAM, one of the highest honors in health and medicine
Good News at Fred Hutch
Solid-tumor faculty retreat fuels immunotherapy and precision-oncology research; Dr. Johnnie Orozco selected to participate in American Society of Hematology faculty-development program
Beau Biden's death highlights difficulty of treating brain cancers
Nearly 14,000 die each year of brain cancer, but researchers are aiming to change that